Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 702471

Benefits of investment into modern medicines in Central-Eastern European countries


Inotai, András; Petrova, Guenka; Vitezić, Dinko; Kaló, Zoltan
Benefits of investment into modern medicines in Central-Eastern European countries // Expert Review of Pharmacoeconomics & Outcomes Research, 14 (2014), 1; 71-79 doi:10.1586/14737167.2014.868314 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 702471 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Benefits of investment into modern medicines in Central-Eastern European countries

Autori
Inotai, András ; Petrova, Guenka ; Vitezić, Dinko ; Kaló, Zoltan

Izvornik
Expert Review of Pharmacoeconomics & Outcomes Research (1473-7167) 14 (2014), 1; 71-79

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
value of innovation ; innovative medicines ; middle income countries ; monetary benefit ; health gain ; productivity ; sustainability ; equity ; responsiveness ; financial protection

Sažetak
Due to the scarcity of health care resources, decision-makers often expect monetary benefits – including cost-savings or productivity gain - from innovative health technologies. Manufacturers try to fulfill this expectation by expressing the benefits of innovative technologies in monetary units citing approaches from the scientific literature. Unfortunately, currently available evidence has limited relevance and transferability in Central-Eastern European countries. This paper aims to summarize how innovative medical therapies in CEE countries may contribute to WHO-defined health system objectives, including health gain, equity in health, financial protection, responsiveness, equity in finance and financial sustainability. References in this paper are also mainly based on international examples ; therefore additional policy research from CEE countries is necessary to validate assumptions. If CEE politicians can rely on credible arguments based on local research evidence, they may improve long-term strategies and policy decisions related to health care innovation.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Projekti:
062-0620063-0060 - Uporaba kardiovaskularnih lijekova i značaj farmakoekonomskih procjena (Vitezić, Dinko, MZOS ) ( CroRIS)

Ustanove:
Medicinski fakultet, Rijeka

Profili:

Avatar Url Dinko Vitezić (autor)

Poveznice na cjeloviti tekst rada:

doi www.tandfonline.com

Citiraj ovu publikaciju:

Inotai, András; Petrova, Guenka; Vitezić, Dinko; Kaló, Zoltan
Benefits of investment into modern medicines in Central-Eastern European countries // Expert Review of Pharmacoeconomics & Outcomes Research, 14 (2014), 1; 71-79 doi:10.1586/14737167.2014.868314 (međunarodna recenzija, članak, znanstveni)
Inotai, A., Petrova, G., Vitezić, D. & Kaló, Z. (2014) Benefits of investment into modern medicines in Central-Eastern European countries. Expert Review of Pharmacoeconomics & Outcomes Research, 14 (1), 71-79 doi:10.1586/14737167.2014.868314.
@article{article, author = {Inotai, Andr\'{a}s and Petrova, Guenka and Vitezi\'{c}, Dinko and Kal\'{o}, Zoltan}, year = {2014}, pages = {71-79}, DOI = {10.1586/14737167.2014.868314}, keywords = {value of innovation, innovative medicines, middle income countries, monetary benefit, health gain, productivity, sustainability, equity, responsiveness, financial protection}, journal = {Expert Review of Pharmacoeconomics and Outcomes Research}, doi = {10.1586/14737167.2014.868314}, volume = {14}, number = {1}, issn = {1473-7167}, title = {Benefits of investment into modern medicines in Central-Eastern European countries}, keyword = {value of innovation, innovative medicines, middle income countries, monetary benefit, health gain, productivity, sustainability, equity, responsiveness, financial protection} }
@article{article, author = {Inotai, Andr\'{a}s and Petrova, Guenka and Vitezi\'{c}, Dinko and Kal\'{o}, Zoltan}, year = {2014}, pages = {71-79}, DOI = {10.1586/14737167.2014.868314}, keywords = {value of innovation, innovative medicines, middle income countries, monetary benefit, health gain, productivity, sustainability, equity, responsiveness, financial protection}, journal = {Expert Review of Pharmacoeconomics and Outcomes Research}, doi = {10.1586/14737167.2014.868314}, volume = {14}, number = {1}, issn = {1473-7167}, title = {Benefits of investment into modern medicines in Central-Eastern European countries}, keyword = {value of innovation, innovative medicines, middle income countries, monetary benefit, health gain, productivity, sustainability, equity, responsiveness, financial protection} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • Social Science Citation Index (SSCI)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font